Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.267, 2000-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Azithromycin, cefaclor preferable in difficult childhood infections
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :
Azithromycin + ceftriaxone as effective as levofloxacin for CAP
Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. :
Azithromycin cost advantage over standard penicillins for treating CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 353, 2002-01 ,pp. :
Azithromycin: cost advantage over standard penicillins for treating CAP
Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. :
Aspirin + dipyridamole preferable for stroke prevention
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :